Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Fact.mr
www.factmr.com/
info@factmr.com
35316111593
Suite 9884 27 Upper Pembroke Street, Dublin 2


Bookmark and Share
Coenzymes Q10 Market Overview: Market Segments, Share and Key Trends Analysis through 2018-2028
The global coenzyme Q10 market to rise at a value CAGR of 9.2% between the period of forecast 2018 and 2028.

BriefingWire.com, 8/10/2018 - Coenzyme Q10 (CoQ10) has been associated with numerous therapeutic benefits in Huntington’s disease and cancer, as well as inherent benefits in medical applications for fostering cardiac health. CoQ10 has sought extensive adoption in the treatment of cognitive ailments, cardiovascular disorders, and periodontal diseases. The WHO foresees the number of cancer patients to increase considerably by 2030-end, which in turn will create high demand for CoQ10 in the near future.

FactMR’s recently collated report offers actionable forecasts on the Global Coenzyme Q10 Market for the period of forecast, 2018 to 2028. Key parameters such as impact of current and future growth determinants & deterrents, expected developments & regulatory scenario, demand statistics, and global raw material procurement & supply are elucidated and analyzed. Influence of these parameters on the coenzyme Q10 market’s growth has been quantified for deriving a market growth rate estimate.

Request a Free Sample Report Here - www.factmr.com/connectus/sample?flag=S&rep_id=732

The U.S. Food and Drug Administration (FDA) designates coenzyme Q10 (CoQ10) as GRAS – Generally Recognized as Safe, implying its safe incorporation as food additive. CoQ10 plays an imperative role in generating majority of energy in a human body. Depleted by the cholesterol lowering medications such as statins, CoQ10 is now becoming an essential requirement in everyday life of consumers worldwide.

Several Diseases have been linked with low CoQ10 levels, which include fibromyalgia, and aftermath of heart attacks (also called as post-myocardial infarction). Parkinson’s disease, migraines, Prader-Willi syndrome, and depression account for CoQ10 deficiency. Currently, over 300 Mn people worldwide are affected by depression according to the WHO.

Additionally, the Parkinson’s Foundation estimates more than 10 Mn individuals suffer from Parkinson’s disease across the globe at present. The National Institutes of Health (NIH) recommends coenzyme Q10 supplementation for patients with Parkinson’s disease. In addition, several studies have depicted reduction in depression and fatigue by CoQ10 supplementation. High prevalence of such diseases is a key demand determinant for CoQ10.

A recently collated, insightful FactMR report foresees the global coenzyme Q10 market to rise at a value CAGR of 9.2% between the period of forecast 2018 and 2028. Roughly 2,670,000 kgs of coenzyme Q10 are pegged to be sold globally by 2028-end.

An endogenously produced compound, coenzyme Q10 is found in human cells, and plays an imperative role in production of energy by serving as mobile electron carrier in electron transport chain within mitochondria. CoQ10 also acts as excellent antioxidant outside mitochondria by working synergistically with various other antioxidants such as vitamin E. Widely available as an OTC supplement, coenzyme Q10 has gained momentum in light of its therapeutic effectiveness in minimizing outcomes of specific metabolic disorders, namely, cancer, neurodegenerative disease, diabetes, and cardiovascular diseases.

View Full Report Here - www.factmr.com/report/732/coenzymes-q10-market

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.